BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, presenting promising enhancements across various health care and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, more trustworthy different for therapeutic use, specific